Long-term ADT Added to RT Improves Outcomes in Prostate Cancer

Androgen deprivation therapy (ADT) given for 24 months in the postoperative setting, combined with radiotherapy, was superior to 6 months of administration for improving metastasis-free survival.
Medscape Medical News